TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17138937

Group type: EXPERIMENTAL
Intervention: Argatroban (350 microg/kg intravenous bolus followed by 25 microg/kg per minute infusion)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Enoxaparin (0.75 mg/kg, intravenous bolus)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 21
Study: 15234137

Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 11
Study: 11318292

Group type: EXPERIMENTAL
Intervention: Topical cyclosporin A (CsA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 24
Study: 9031498

Group type: EXPERIMENTAL
Intervention: FUT1 alleles with T460C mutation
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: FUT1 alleles with G1042A mutation
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: FUT1 alleles with both T460C and G1042A mutations
Number of subjects: 1
Study: 8293898

Group type: EXPERIMENTAL
Intervention: Direct current electrocoagulation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bipolar electrocoagulation
Number of subjects: 50
Study: 2965231

Group type: EXPERIMENTAL
Intervention: Isradipine (5.1 mg twice daily)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Isradipine (long-term follow-up)
Number of subjects: 17
Study: 30962918

Group type: EXPERIMENTAL
Intervention: Tailoring arm (HAPA-based interventions)
Number of subjects: 12

Group type: COMPARATOR
Intervention: ASH arm (untailored educational sessions)
Number of subjects: 12
Study: 29535504

Group type: EXPERIMENTAL
Intervention: HTX-019 (130 mg) IV over 30 min
Number of subjects: 97

Group type: COMPARATOR
Intervention: Fosaprepitant (150 mg) IV over 30 min
Number of subjects: 97
Study: 27966411

Group type: EXPERIMENTAL
Intervention: Christmas joy (JN) intervention for three days
Number of subjects: 24

Group type: COMPARATOR
Intervention: No Christmas joy (JN)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Christmas joy (JN) intervention
Number of subjects: 24
Study: 25065855

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200 mg weekly for 5 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 19
Study: 23318239

Group type: EXPERIMENTAL
Intervention: Community-centered dengue-ecosystem management intervention in Demangan and Giwangan neighborhoods
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group with no intervention in Tahunan and Bener neighborhoods
Number of subjects: 6
Study: 19231284

Group type: EXPERIMENTAL
Intervention: High intensity exercise (15 min duration)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (15 min duration)
Number of subjects: 60
Study: 17411338

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) including protease inhibitor or non-nucleoside reverse transcriptase inhibitor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 0
Study: 16338284

Group type: EXPERIMENTAL
Intervention: 4-mg nicotine gum
Number of subjects: 364

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 364
Study: 12221873

Group type: EXPERIMENTAL
Intervention: Xe:O2 (70:30)
Number of subjects: 44

Group type: COMPARATOR
Intervention: N2O:O2 (70:30) + phentanyl (0.1 ml boluses every 20 min)
Number of subjects: 44
Study: 10076584

Group type: EXPERIMENTAL
Intervention: Food label education program (9 weekly group sessions)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study: 8562295

Group type: COMPARATOR
Intervention: Grapefruit juice
Number of subjects: 12
Study: 2266681

Group type: EXPERIMENTAL
Intervention: Cuprophane membrane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polymethylmethacrylate membrane
Number of subjects: 0
Study: 7367779

Group type: EXPERIMENTAL
Intervention: Intranasal beclomethasone dipropionate aerosol (BDA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31294822

Group type: EXPERIMENTAL
Intervention: Heavier loads (>60% of maximal strength) during resistance exercise to task failure
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lighter loads during resistance exercise to task failure
Number of subjects: 10
Study: 27507127

Group type: EXPERIMENTAL
Intervention: Essix retainer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hawley retainer
Number of subjects: 30
Study: 26190299

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 milliamps for 20 minutes, 5 sessions)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 37
Study: 24427796

Group type: EXPERIMENTAL
Intervention: Tecnis ZCB00 continuous-optic-edge IOL
Number of subjects: 54

Group type: COMPARATOR
Intervention: Acrysof SA60AT interrupted-optic-edge IOL
Number of subjects: 54
Study: 21487425

Group type: EXPERIMENTAL
Intervention: Multi-component family focused education package (active intervention)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Waiting list control group (body composition monitoring alone)
Number of subjects: 65
Study: 19782788

Group type: EXPERIMENTAL
Intervention: Doppler-echocardiographic measures of LV diastolic function (MV E/A, E/E')
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Doppler-echocardiographic measures of LV diastolic function (MV E/A)
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Doppler-echocardiographic measures of LV diastolic function
Number of subjects: 2331
Study: 17255296

Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy in the metastatic setting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant strategies integrating aggressive surgical intervention with systemic therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New targeted therapies
Number of subjects: 0
Study: 15119639

Group type: EXPERIMENTAL
Intervention: Early start dialysis (10-14 mL/min/1.73 m2)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Late start dialysis (5-7 mL/min/1.73 m2)
Number of subjects: 388
Study: 11268891

Group type: EXPERIMENTAL
Intervention: Fusidic acid 500 mg twice a day for 7.5 days
Number of subjects: 313

Group type: COMPARATOR
Intervention: Pristinamycin 1 g twice a day for 10 days
Number of subjects: 313
Study: 9852937

Group type: EXPERIMENTAL
Intervention: Thrombolysis initiated by prehospital care providers (physicians or paramedics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prehospital ECG acquisition and interpretation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prehospital identification of thrombolysis-eligible patients
Number of subjects: 0
Study: 7810300

Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Insertion of a grommet
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Adenoidectomy + grommet insertion
Number of subjects: 222

Group type: COMPARATOR
Intervention: No surgical procedure (control)
Number of subjects: 222
Study: 3935853

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (cephalosporin treatment alone: cefotaxime, cefazolin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of two or three antibiotics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (general)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wider antibiotic spectrum
Number of subjects: 0
Study: 31821322

Group type: EXPERIMENTAL
Intervention: 1-kg/m2 BMI reduction
Number of subjects: 287394
Study: 29486504

Group type: EXPERIMENTAL
Intervention: Hippotherapy (once to twice weekly for 16 to 20 weeks, mean: 17 treatments)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Hippotherapy (early treatment group)
Number of subjects: 73
Study: 26254755

Group type: EXPERIMENTAL
Intervention: Amiodarone hydrogel
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Corticosteroid hydrogel (triamcinolone)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (hydrogel only)
Number of subjects: 150
Study: 25312315

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma (5 mL in two applications)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Oral paracetamol (1 gr every 8 hours for 30 days)
Number of subjects: 42
Study: 22701534

Group type: EXPERIMENTAL
Intervention: 2.5 MP commercial color LCD
Number of subjects: 5

Group type: COMPARATOR
Intervention: 3 MP diagnostic monochrome LCD
Number of subjects: 5
Study: 20393269

Group type: EXPERIMENTAL
Intervention: Acute pressure applied to the sciatic nerve (11 to 20 kg for 2 minutes)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo intervention (pressure applied to parallel regions on the fronts of the thighs)
Number of subjects: 174
Study: 17660520

Group type: EXPERIMENTAL
Intervention: Remifentanil at 1 ng ml(‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Remifentanil at 3 ng ml(‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Remifentanil at 5 ng ml(‐1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tet30 (30 s tetanic stimulus)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tet5 (5 s tetanic stimulus)
Number of subjects: 33
Study: 17962011

Group type: EXPERIMENTAL
Intervention: Telemedicine linkage to breast specialists in a cancer centre
Number of subjects: 473

Group type: COMPARATOR
Intervention: In-person meetings
Number of subjects: 473
Study: 14732596

Group type: EXPERIMENTAL
Intervention: High-dose glycine (0.8 g/kg/day)
Number of subjects: 17
Study: 10730723

Group type: EXPERIMENTAL
Intervention: Preventive oral hygiene program including instruction of the carers and implementation of a recall program for professional oral hygiene care
Number of subjects: 237

Group type: COMPARATOR
Intervention: Control group (no preventive oral hygiene program)
Number of subjects: 237
Study: 8831317

Group type: EXPERIMENTAL
Intervention: 1.73% lidocaine with 10 micrograms/mL of clonidine (Group C10)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 1.73% lidocaine (Group L)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 1.73% lidocaine with 20 micrograms/mL clonidine (Group C20)
Number of subjects: 90
Study: 1279289

Group type: EXPERIMENTAL
Intervention: Terbutaline (5 mg three times daily)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily) with Terbutaline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 4018101

Group type: EXPERIMENTAL
Intervention: Breast feeding (BF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early formula feeding (F)
Number of subjects: 0
Study: 30706247

Group type: EXPERIMENTAL
Intervention: T-DM1 (3.6 mg/kg q3w, 2.4 mg/kg qw)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Taxane (docetaxel/paclitaxel)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: T-DM1 (2.4 mg/kg qw)
Number of subjects: 345
Study: 28823926

Group type: EXPERIMENTAL
Intervention: One-step GDM screening strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-step GDM screening strategy
Number of subjects: 0
Study: 25732415

Group type: COMPARATOR
Intervention: Forward View (FV)
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Retroflexion View (RV)
Number of subjects: 850
Study: 23899791

Group type: EXPERIMENTAL
Intervention: Education intervention (2-hour informative session and non-supervised physical activity programme)
Number of subjects: 756

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 756
Study: 21937808

Group type: COMPARATOR
Intervention: Endoscopic band ligation (ligation group)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Splenectomy and perisoph‐agogastric devascularization (laparotomy group)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Laparoscopic splenectomy, perisoph‐agogastric devascularization and endoscopic variceal ligation (combination group)
Number of subjects: 105
Study: 19155351

Group type: EXPERIMENTAL
Intervention: Percutaneous intramuscular electrical stimulation for hand opening (n = 13)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Percutaneous electrical stimulation for sensory stimulation only (n = 13)
Number of subjects: 26
Study: 17911040

Group type: EXPERIMENTAL
Intervention: Stimulant medications
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmedicated girls (Control)
Number of subjects: 0
Study: 15019537

Group type: EXPERIMENTAL
Intervention: Micronised fenofibrate (200 mg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Vitamin E (500 mg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination of fenofibrate and Vitamin E
Number of subjects: 36
Study: 12500879

Group type: EXPERIMENTAL
Intervention: Dental implants
Number of subjects: 409

Group type: COMPARATOR
Intervention: Natural teeth
Number of subjects: 409

Group type: COMPARATOR
Intervention: Natural teeth and implants
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Periotest
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Changes in PTVs
Number of subjects: 409
Study: 9141204

Group type: EXPERIMENTAL
Intervention: 20 micrograms Engerix-B vaccine
Number of subjects: 52

Group type: COMPARATOR
Intervention: 40 micrograms Engerix-B vaccine
Number of subjects: 52
Study: 7536068

Group type: EXPERIMENTAL
Intervention: Nylon wool exposure
Number of subjects: 14
Study: 3319012

Group type: EXPERIMENTAL
Intervention: 1 g aztreonam
Number of subjects: 179

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study: 30796598

Group type: EXPERIMENTAL
Intervention: New peanut allergen treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 30412221

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (IC) with TPF (docetaxel, cisplatin, 5-FU omitted in subsequent patients) followed by radiotherapy (69.6 Gy)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Cetuximab added to induction chemotherapy (IC) with TPF followed by radiotherapy (69.6 Gy)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Induction chemotherapy (IC) with TPF followed by radiotherapy (69.6 Gy)
Number of subjects: 173
Study: 27077348

Group type: EXPERIMENTAL
Intervention: Na‐reduction intervention
Number of subjects: 975

Group type: COMPARATOR
Intervention: Control
Number of subjects: 975
Study: 24215123

Group type: EXPERIMENTAL
Intervention: Concrete construal diaries
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mindful self-compassionate meditation programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abstract construal diaries
Number of subjects: 0
Study: 22377815

Group type: EXPERIMENTAL
Intervention: Propranolol LA (240 mg/day)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Topiramate alone (50-100 mg/day)
Number of subjects: 191
Study: 19615827

Group type: EXPERIMENTAL
Intervention: Compassion meditation training
Number of subjects: 32

Group type: COMPARATOR
Intervention: TSST administered prior to compassion meditation training
Number of subjects: 32
Study: 18752682

Group type: EXPERIMENTAL
Intervention: High protein meal replacement (HP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard protein meal replacement (SP)
Number of subjects: 100
Study: 16006194

Group type: COMPARATOR
Intervention: Omega-3 fatty acid supplementation (1 g eicosapentaenoic acid (EPA) and 0.7 g docosahexaenoic acid (DHA) daily)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Omega-3 fatty acid supplementation
Number of subjects: 57
Study: 12061623

Group type: EXPERIMENTAL
Intervention: Testimonial consistency (consistent)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Testimonial consistency (inconsistent)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Witness confidence (high)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Witness confidence (low)
Number of subjects: 130
Study: 9859905

Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (NCPAP)
Number of subjects: 34
Study: 8725038

Group type: EXPERIMENTAL
Intervention: 40 mg BCG therapy
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 80 mg BCG therapy
Number of subjects: 111
Study: 2094375

Group type: EXPERIMENTAL
Intervention: Thymic extracts (TP1)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 352142

Group type: EXPERIMENTAL
Intervention: Duck Embryo Vaccine (DEV), 4 doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WI-38 Vaccine (WRV), 4 doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WI-38 Vaccine (WRV), 2 doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WI-38 Vaccine (WRV), 3 or 4 doses
Number of subjects: 0
Study: 31789778

Group type: EXPERIMENTAL
Intervention: HealthVoyager (VR experience)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard practice (printed reports)
Number of subjects: 41
Study: 31029515

Group type: COMPARATOR
Intervention: 10-10-PLAIN (non-adjuvanted formulation)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10-10-AS01 (AS01-adjuvanted formulation with 10 µg of each antigen)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10-3-AS01 (AS01-adjuvanted formulation with 10 µg of each NTHi antigen and 3.3 µg of Mcat antigen)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 28662170

Group type: EXPERIMENTAL
Intervention: healthMpowerment online intervention
Number of subjects: 465
Study: 26488693

Group type: EXPERIMENTAL
Intervention: Nicotinamide 500 mg twice daily
Number of subjects: 386

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 386
Study: 23360885

Group type: EXPERIMENTAL
Intervention: Dexketoprofen 50 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 60
Study: 21459987

Group type: EXPERIMENTAL
Intervention: CBT-GSH
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study: 19124698

Group type: EXPERIMENTAL
Intervention: Smoking in the film trailer (42 seconds, character smoked for about 3 seconds)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Nonsmoking film trailer (control)
Number of subjects: 1051
Study: 17077229

Group type: EXPERIMENTAL
Intervention: CDB‐2914 (50 mg single dose)
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Levonorgestrel (0.75 mg two doses taken 12 hours apart)
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: CDB‐2914
Number of subjects: 1549

Group type: COMPARATOR
Intervention: Levonorgestrel
Number of subjects: 1549
Study: 15039761

Group type: EXPERIMENTAL
Intervention: Sustained release d‐amphetamine (escalating 15‐30 or 30‐60 mg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Risperidone (2 or 4 mg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 11547367

Group type: EXPERIMENTAL
Intervention: Cemented acetabular components
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cementless acetabular components
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cementless components
Number of subjects: 90
Study: 9097530

Group type: EXPERIMENTAL
Intervention: Ivermectin (100 micrograms/kg, two single doses, 3 months apart)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 8242317

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (25 Gy in five fractions over 1 week)
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1168

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 1168
Study: 2871216

Group type: EXPERIMENTAL
Intervention: Renal tubular dysfunction assessment in stone formers
Number of subjects: 214
Study: 30459468

Group type: COMPARATOR
Intervention: Sham deep breathing
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: OPEP
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: OPEP + OIS
Number of subjects: 13
Study: 28715809

Group type: EXPERIMENTAL
Intervention: Suction drains (group 1; n = 108)
Number of subjects: 215

Group type: COMPARATOR
Intervention: No suction drains (group 2; n = 107)
Number of subjects: 215
Study: 26386381

Group type: EXPERIMENTAL
Intervention: Honey based formulation of Nigella sativa seed oil (5 ml N. sativa oil orally daily) for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 23000726

Group type: EXPERIMENTAL
Intervention: Tulobuterol patches (1-2mg daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Theophylline (4-5mg/kg daily)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 22166100

Group type: EXPERIMENTAL
Intervention: Statistical framework for assessing uncertainty prior to patient recruitment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expert panel opinions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decision rule selected
Number of subjects: 0
Study: 19087899

Group type: EXPERIMENTAL
Intervention: TSD and paroxetine treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TSD and 2 weeks of placebo followed by paroxetine treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: 2 weeks of paroxetine treatment
Number of subjects: 16
Study: 17070644

Group type: EXPERIMENTAL
Intervention: Hands‐Off Technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard Hand Position
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Two‐Finger Fulcrum Technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Five‐Finger Fulcrum Technique
Number of subjects: 30
Study: 15330779

Group type: EXPERIMENTAL
Intervention: Outdoor air supply rate at 10 l/s/p and temperature at 24.5 degrees C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outdoor air supply rate at 5 l/s/p and temperature at 22.5 degrees C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Outdoor air supply rate at 5 l/s/p and temperature at 24.5 degrees C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temperature reduction from 24.5 degrees C to 22.5 degrees C at 10 l/s/p
Number of subjects: 0
Study: 11094581

Group type: EXPERIMENTAL
Intervention: Amiodarone (900 mg per 24 h)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Magnesium (4 g per 24 h)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl; 50 ml per 24 h)
Number of subjects: 155
Study: 8833058

Group type: EXPERIMENTAL
Intervention: Triple therapy (MTX 17.5 mg/week, sulfasalazine 500 mg bid, hydroxychloroquine 200 mg bid)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Combination of hydroxychloroquine and sulfasalazine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Methotrexate alone
Number of subjects: 28